Sildenafil
Remidia contains the active substance sildenafil, which belongs to a group of medicines called phosphodiesterase type 5 inhibitors (PDE5).
Remidia lowers blood pressure in the lungs by relaxing blood vessels.
Remidia is used to treat high blood pressure in the pulmonary arteries (pulmonary arterial hypertension) in adults, children, and adolescents from 1 to 17 years of age.
Before taking Remidia, discuss it with your doctor.
Tell your doctor about:
During treatment with phosphodiesterase type 5 inhibitors, including sildenafil, the following side effects have been reported, with unknown frequency, related to vision disorders: partial, unexpected, transient, or permanent loss of vision, or decreased vision in one or both eyes.
In case of sudden loss of vision, stop taking Remidia and immediately consult a doctor(see also section 4).
In men taking sildenafil, prolonged and sometimes painful erections have been observed. In case of an erection lasting longer than 4 hours, stop taking Remidia and immediately consult a doctor(see also section 4).
Taking the medicine in patients with kidney or liver disease
Tell your doctor if you have kidney or liver disease, as it may be necessary to adjust the dose of the medicine.
Remidia should not be used in children under 1 year of age.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take.
Do not drink grapefruit juice while taking Remidia.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Remidia should only be used during pregnancy if it is absolutely necessary.
It is not recommended to use Remidia in women of childbearing age unless they use appropriate contraceptive methods.
Remidia passes into breast milk in very small amounts and is not expected to harm the baby.
Remidia may cause dizziness and vision disturbances. Check your reaction to the medicine before driving or operating machinery.
If you have been told that you have an intolerance to some sugars, contact your doctor before taking the medicine.
The medicine contains less than 1 mmol of sodium (23 mg) per tablet, which means it is essentially sodium-free.
Always take this medicine exactly as your doctor has told you.
In case of doubt, consult your doctor or pharmacist.
The recommended dose for adults is 20 mg three times a day (taken every 6-8 hours), with or without food.
For children and adolescents from 1 to 17 years of age, the recommended dose is 10 mg three times a day for children and adolescents with a body weight of ≤20 kg or 20 mg three times a day for children and adolescents with a body weight of >20 kg, with or without food. Do not use higher doses in children. This medicine should only be used when a dose of 20 mg three times a day is given. For patients with a body weight of ≤20 kg and other younger patients who cannot swallow tablets, another medicinal product containing sildenafil in an appropriate pharmaceutical form - suspension - is available.
Do not take more than the recommended dose of the medicine.
If you have taken more than the recommended dose of the medicine, contact your doctor immediately. Taking more than the recommended dose of Remidia may increase the risk of side effects.
If you miss a dose of Remidia, take it as soon as possible and continue taking the medicine as scheduled. Do not take a double dose to make up for a missed dose.
Sudden withdrawal of Remidia may worsen your condition. Do not stop taking the medicine without consulting your doctor. Your doctor may decide to gradually reduce the dose of the medicine over several days before stopping treatment.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Remidia can cause side effects, although not everybody gets them.
If you experience any of the following side effects, stop taking Remidia and consult a doctor immediately(see also section 2):
Adults
Very common (affecting more than 1 in 10 people) side effects include: headache, sudden reddening of the face, indigestion, diarrhea, and pain in the arms or legs.
Common (affecting less than 1 in 10 people) side effects include:
subcutaneous infections, flu-like symptoms, sinusitis, decreased red blood cell count (anemia), fluid retention, difficulty sleeping, anxiety, migraine, tremors, tingling, burning sensation, decreased skin sensitivity, bleeding in the back of the eye, vision disturbances, blurred vision, increased sensitivity to light, color vision disturbances, eye irritation, conjunctival congestion (red eyes), dizziness, bronchitis, nosebleeds, runny nose, cough, inflammation of the stomach and intestines, heartburn, hemorrhoids, bloating, dry mouth, hair loss, skin reddening, night sweats, muscle pain, back pain, and increased body temperature.
Uncommon (affecting less than 1 in 100 people) side effects include:
decreased visual acuity, double vision, abnormal eye sensations, penile bleeding, blood in semen and/or urine, and breast enlargement in men.
Also reported with unknown frequency (frequency cannot be estimated from available data): skin rash, sudden hearing loss, and decreased blood pressure.
Children and adolescents
The following serious side effects have been reported: pneumonia, heart failure, right ventricular failure, cardiogenic shock, increased pulmonary arterial pressure, chest pain, syncope, respiratory tract infections, bronchitis, viral gastroenteritis, urinary tract infections, and tooth decay.
Serious side effects considered to be related to treatment and reported with unknown frequency (affecting less than 1 in 100 people) include:
allergic reactions (such as skin rash, face, lips, tongue, or throat swelling, wheezing, difficulty breathing or swallowing), seizures, irregular heartbeat, hearing disturbances, shortness of breath, gastrointestinal inflammation, wheezing due to airway obstruction.
Very common (affecting more than 1 in 10 people) side effects include: headache, vomiting, throat infections, fever, diarrhea, flu, and nosebleeds.
Common (affecting less than 1 in 10 people) side effects include:
nausea, increased frequency of erections, pneumonia, and runny nose.
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of Medicinal Products, Medical Devices, and Biocidal Products
Jerozolimskie Avenue 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
There are no special precautions for storage.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
The inscription on the packaging after the abbreviation EXP means the expiry date, and after the abbreviation Lot/LOT means the batch number.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Remidia is a white, round, biconvex, film-coated tablet with a diameter of 5 mm, in a cardboard box.
The pack contains 90 film-coated tablets.
Zakłady Farmaceutyczne POLPHARMA S.A.
Pelplińska 19, 83-200 Starogard Gdański
Phone: +48 22 364 61 01
Date of last revision of the leaflet:June 2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.